Elanco Animal Health (ELAN) Short-Term Debt issuances (2021 - 2025)

Elanco Animal Health has disclosed Short-Term Debt issuances across 5 years of filings, most recently posting $125.0 million for Q1 2025.

• Short-Term Debt issuances for Q1 2025 came in at $125.0 million, up 150.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $125.0 million (down 26.47% YoY), and the FY2025 annual result was $125.0 million, down 26.47% from the prior year.
• Short-Term Debt issuances came in at $125.0 million for Q1 2025 at Elanco Animal Health, up from $120.0 million in the prior quarter.
• In the past five years, Short-Term Debt issuances ranged from a high of $500.0 million in Q2 2022 to a low of -$563.0 million in Q4 2022.
• The 5-year median for Short-Term Debt issuances is $110.0 million (2023), against an average of $69.5 million.
• Across the five-year window, Short-Term Debt issuances slumped 58.0% in 2022 and soared 150.0% in 2025, its largest moves.
• Elanco Animal Health's Short-Term Debt issuances stood at $150.0 million in 2021, then sank by 475.33% to -$563.0 million in 2022, then surged by 82.24% to -$100.0 million in 2023, then surged by 220.0% to $120.0 million in 2024, then gained by 4.17% to $125.0 million in 2025.
• The last three Short-Term Debt issuances figures came in at $125.0 million (Q1 2025), $120.0 million (Q2 2024), and $50.0 million (Q1 2024), per Business Quant data.